Pfizer, Inc. (PFE) Tops Q1 EPS by 2c; Cuts FY12 Outlook

May 1, 2012 7:00 AM EDT Send to a Friend
Get Alerts PFE Hot Sheet
Trade PFE Now!
Join SI Premium – FREE
Pfizer, Inc. (NYSE: PFE) reported Q1 EPS of $0.58, $0.02 better than the analyst estimate of $0.56. Revenue for the quarter came in at $15.4 billion versus the consensus estimate of $15.47 billion.

Sees FY12 adj-EPS of $2.14-$2.24 on sales of $58-$60 billion. The Street is currently expecting FY12 EPS of $2.26 on sales of $62.14 billion. Pfizer had previously guided FY12 adj-EPS to $2.20-$2.30 on sales of $60.5-$62.5 billion.

For earnings history and earnings-related data on Pfizer, Inc. (PFE) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance, Hot Guidance, Hot List

Related Entities

Earnings

Add Your Comment